Vitamin D and COVID-19 severity and related mortality: a prospective study in Italy

被引:78
作者
Campi, Irene [1 ,2 ,3 ]
Gennari, Luigi [4 ]
Merlotti, Daniela [4 ]
Mingiano, Christian [4 ]
Frosali, Alessandro [4 ]
Giovanelli, Luca [1 ,2 ,5 ]
Torlasco, Camilla [6 ,7 ]
Pengo, Martino F. [6 ,7 ]
Heilbron, Francesca [6 ,7 ]
Soranna, Davide [8 ]
Zambon, Antonella [8 ,9 ]
Di Stefano, Marta [1 ,2 ,5 ]
Aresta, Carmen [1 ,2 ,5 ]
Bonomi, Marco [1 ,2 ,5 ]
Cangiano, Biagio [1 ,2 ,5 ]
Favero, Vittoria [1 ,2 ,5 ]
Fatti, Letizia [1 ,2 ,5 ]
Perego, Giovanni Battista [6 ]
Chiodini, Iacopo [1 ,2 ,5 ]
Parati, Gianfranco [6 ,7 ]
Persani, Luca [1 ,2 ,5 ]
机构
[1] Ist Auxol Italiano, Dept Endocrine & Metab Dis, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[2] Ist Auxol Italiano, Lab Endocrine & Metab Res, IRCCS, Via Magnasco 2, I-20149 Milan, Italy
[3] Univ Milan, Dept Pathophysiol & Transplantat, Milan, Italy
[4] Univ Siena, Dept Med Surg & Neurosci, Siena, Italy
[5] Univ Milan, Dept Clin Sci & Community Hlth, Milan, Italy
[6] Ist Auxol Italiano, Dept Cardiovasc Neural & Metab Sci, IRCCS, Milan, Italy
[7] Univ Milano Bicocca, Dept Med & Surg, I-20100 Milan, Italy
[8] IRCCS Ist Auxol Italiano, Biostat Unit, Milan, Italy
[9] Univ Milano Bicocca, Dept Stat & Quantitat Methods, Milan, Italy
关键词
Vitamin D; COVID-19; Mortality; Interleukin-6; TOCILIZUMAB; DEFICIENCY; RISK;
D O I
10.1186/s12879-021-06281-7
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Background Vitamin D deficiency has been suggested to favor a poorer outcome of Coronavirus disease-19 (COVID-19). We aimed to assess if 25-hydroxyvitamin-D (25OHD) levels are associated with interleukin 6 (IL-6) levels and with disease severity and mortality in COVID-19. Methods We prospectively studied 103 in-patients admitted to a Northern-Italian hospital (age 66.1 +/- 14.1 years, 70 males) for severely-symptomatic COVID-19. Fifty-two subjects with SARS-CoV-2 infection but mild COVID-19 symptoms (mildly-symptomatic COVID-19 patients) and 206 subjects without SARS-CoV-2 infection were controls. We measured 25OHD and IL-6 levels at admission and focused on respiratory outcome during hospitalization. Results Severely-symptomatic COVID-19 patients had lower 25OHD levels (18.2 +/- 11.4 ng/mL) than mildly-symptomatic COVID-19 patients and non-SARS-CoV-2-infected controls (30.3 +/- 8.5 ng/mL and 25.4 +/- 9.4 ng/mL, respectively, p < 0.0001 for both comparisons). 25OHD and IL-6 levels were respectively lower and higher in severely-symptomatic COVID-19 patients admitted to intensive care Unit [(ICU), 14.4 +/- 8.6 ng/mL and 43.0 (19.0-56.0) pg/mL, respectively], than in those not requiring ICU admission [22.4 +/- 1.4 ng/mL, p = 0.0001 and 16.0 (8.0-32.0) pg/mL, p = 0.0002, respectively]. Similar differences were found when comparing COVID-19 patients who died in hospital [13.2 +/- 6.4 ng/mL and 45.0 (28.0-99.0) pg/mL] with survivors [19.3 +/- 12.0 ng/mL, p = 0.035 and 21.0 (10.5-45.9) pg/mL, p = 0.018, respectively). 25OHD levels inversely correlated with: i) IL-6 levels (rho - 0.284, p = 0.004); ii) the subsequent need of the ICU admission [relative risk, RR 0.99, 95% confidence interval (95%CI) 0.98-1.00, p = 0.011] regardless of age, gender, presence of at least 1 comorbidity among obesity, diabetes, arterial hypertension, creatinine, IL-6 and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count; iii) mortality (RR 0.97, 95%CI, 0.95-0.99, p = 0.011) regardless of age, gender, presence of diabetes, IL-6 and C-reactive protein and lactate dehydrogenase levels, neutrophil cells, lymphocytes and platelets count. Conclusion In our COVID-19 patients, low 25OHD levels were inversely correlated with high IL-6 levels and were independent predictors of COVID-19 severity and mortality.
引用
收藏
页数:13
相关论文
共 52 条
[51]   Effective treatment of severe COVID-19 patients with tocilizumab [J].
Xu, Xiaoling ;
Han, Mingfeng ;
Li, Tiantian ;
Sun, Wei ;
Wang, Dongsheng ;
Fu, Binqing ;
Zhou, Yonggang ;
Zheng, Xiaohu ;
Yang, Yun ;
Li, Xiuyong ;
Zhang, Xiaohua ;
Pan, Aijun ;
Wei, Haiming .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (20) :10970-10975
[52]   A modified Poisson regression approach to prospective studies with binary data [J].
Zou, GY .
AMERICAN JOURNAL OF EPIDEMIOLOGY, 2004, 159 (07) :702-706